103 Residual work capacity and (in)ability to work fulltime among applicants with cancer CONCLUSION The findings of this study showed that the prevalence of cancer patients who have no work capacity 2 years after being diagnosed is high (42.6%). Additionally, of those who have residual work capacity, about 70% is assessed as being unable to work fulltime. This means that only 15% of all applicants with cancer are assessed by the insurance physician with a normal ability to work fulltime 2 years after the start of their sick leave. Our findings show that the type of cancer seems to be important in terms of residual work capacity and the ability to work fulltime as shown by significant differences on these assessment outcomes between the specific diagnosis. The findings of this study can contribute to a more evidence-based assessment of residual work capacity and inability to work fulltime in disability claim assessments, providing insight into which workers within specific cancer diagnosis groups are at risk for no residual work capacity and inability to work fulltime. 5
RkJQdWJsaXNoZXIy MTk4NDMw